Designing therapeutic proteins that avoid unwanted immune responses is a major challenge in biotechnology. A recent study in ImmunoInformatics addresses this challenge with an innovative method: CAPE-XVAE. The paper, “Guiding a Language-Model Based Protein Design Method Towards MHC Class-I Immune-Visibility Targets in Vaccines and Therapeutics,” presents this novel approach for deimmunizing therapeutic proteins. Background Therapeutic … Read more
